Press Releases

 Filter by Provider

SEATTLE and SINGAPORE, April 15, 2026 (GLOBE NEWSWIRE) -- Callio Therapeutics, a biotherapeutics company advancing dual-payload antibody-drug conjugates (ADCs) with a targeted, multi-mechanism approach to cancer treatment, today announced a poster presentation on CLIO-8221 at the American Association of Cancer Research (AACR) Annual Meeting 2026 (April 17-22, San Diego). CLIO-8221, currently being evaluated in an ongoing Phase 1 trial, is a first-in-class dual-payload ADC, engineered for targeted delivery of two payload classes, a topoisomerase 1 (Topo1) inhibitor and an ATR inhibitor, to HER2-expressing tumors.

BOSTON, April 15, 2026 (GLOBE NEWSWIRE) -- Folia Health announces the launch of Burden and Real-world Assessment of Caregiver Voice and Experiences in Prader-Willi syndrome (BRAVE-PWS), a fully remote observational study, sponsored by Soleno Therapeutics (NASDAQ: SLNO), designed to better understand the real-world experience of caregivers supporting individuals with Prader-Willi syndrome (PWS). The study will use Folia’s app-based platform to collect Home-Reported Outcomes (HROs) and longitudinal caregiver-reported data over six months, helping researchers characterize the day-to-day experience associated with PWS and identify the factors that most affect caregiver well-being and household functioning.

New Growth Agent integrates MX’s data-driven intelligence with Primitive’s agentic operating system to redefine the scale of human-AI collaboration in modern banking

Any Class, Every Repair. Fleets Can Now Centralize Repair Operations Across All Vehicles.

WEST PALM BEACH, Fla., April 15, 2026 (GLOBE NEWSWIRE) -- Sunrise Realty Trust, Inc. (“SUNS”) (Nasdaq: SUNS), a lender on the Tannenbaum Capital Group (“TCG”) Real Estate platform, today announced that it will release its financial results for the first quarter ended March 31, 2026, on Thursday, May 14, 2026, before market open. Management will review SUNS’ financial results at 10:00 am ET via webcast available on the Investor Relations website at ir.sunriserealtytrust.com. Participants are also invited to access the conference call by registering in advance at this link. A replay will be available one hour after the event.

Institutional Clients Can Now Trade Derivatives with a Principal Dealer Directly from Custody — Eliminating Counterparty Risk While Preserving Full Market Access

Medford, OR, April 15, 2026 (GLOBE NEWSWIRE) -- Next Wednesday, April 22, 2026, The Human Bean is hosting its annual Earth Day Giveback at all U.S. locations. Every drink sold plants one tree through Trees for the Future, an international nonprofit with 30+ years of experience planting hundreds of millions of trees and teaching sustainable farming practices to coffee farmers worldwide.

SAN FRANCISCO, April 15, 2026 (GLOBE NEWSWIRE) -- Following its prior announcement that it has entered into a definitive agreement to sell the Allbirds brand and footwear assets to American Exchange Group, which intends to continue to build on Allbirds’ legacy and deliver compelling products to Allbirds’ customers (the “Asset Sale”), Allbirds, Inc. (Nasdaq: BIRD) (the "Company") today announced the execution of a definitive agreement with an institutional investor for a $50 million convertible financing facility (the “Facility”). The Facility, which is expected to close during the second quarter of 2026, will enable the Company to pivot its business to AI compute infrastructure, with a long-term vision to become a fully integrated GPU-as-a-Service (GPUaaS) and AI-native cloud solutions provider. In connection with this pivot, the Company anticipates changing its name to “NewBird AI.”

Kei will serve as Audit Committee Chair, a key appointment as the company prepares to enter the U.S. public markets

MARKHAM, Ontario, April 15, 2026 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.0441 per common share of the Company for the month of April 2026, which is payable on May 15, 2026 to shareholders of record at the close of business on April 30, 2026. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).

Division surpasses $835 million in total credits since inception, with significant momentum driven by recent years of expansion in historic rehabilitation and community revitalization nationwide

MIAMI, April 15, 2026 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing a fully human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and other autoimmune diseases, today announced that the Company will give an oral presentation and multiple poster presentations at the 21st Immunology of Diabetes Society (IDS) Congress being held April 20-24, 2026, in Brisbane, Australia. Data to be presented will highlight SAB BIO’s lead program, SAB-142, a potentially best-in-class, disease-modifying, redosable immunotherapy in clinical development for newly diagnosed Stage 3 T1D patients.

Mastercard and BNP Paribas veteran to accelerate expansion of Reward across key global markets as Rezolve Ai deepens its position at the intersection of banking, commerce and AI

SAN DIEGO, April 15, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, will participate in RedChip’s upcoming virtual investor conference, “Biotech Resurgence: Platforms and Pipelines of Today’s Innovators,” taking place April 16, 2026, from 9:30 a.m. to 4:00 p.m. E.T.

NEWARK, N.J., April 15, 2026 (GLOBE NEWSWIRE) -- NeenOpal, a global leader in high-velocity AI automation and cloud modernization, announced today that it has achieved the Amazon Web Services (AWS) AI Competency in the Generative AI and Agentic AI categories. This specialization recognizes NeenOpal as an AWS Partner that helps customers and the AWS Partner Network (APN) drive the advancement of services, tools, and infrastructure pivotal for implementing AI technologies, including both generative and autonomous AI systems.

LONDON, Ontario, April 15, 2026 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, announced that it has filed its interim condensed consolidated financial results for the three and nine months ended February 28, 2026, and is pleased to provide the following highlights. Unless otherwise indicated, all financial information in this press release is reported in Canadian dollars.

WEST PALM BEACH, Fla., April 15, 2026 (GLOBE NEWSWIRE) -- AFC today announced that it will release its financial results for the first quarter ended March 31, 2026, on Thursday, May 7, 2026, before market open. Management will review AFC’s financial results at 10:00 am ET via webcast available on the Investor Relations section of AFC’s website found here AFC -- Investor Relations. Participants are also invited to access the conference call by registering in advance at this link. A replay will be available one hour after the event.

ACMA National Conference features leaders and professionals affiliated with case management and transitions of care taking place April 20-23 in Orlando, Florida

Strategic partnership makes AMC’s popular and critically acclaimed content accessible to buyers through a single access point

New conversational interface makes it easy for teams to launch, monitor, and guide agentic PXM workflows without technical expertise

Following its 2026 Annual Member Summit, AMGTA today released Additive Manufacturing in Resource-Efficient Manufacturing Systems, an independent report establishing how additive manufacturing should be evaluated, communicated, and deployed across part, system, and enterprise levels.

Regulatory News:

Options Technology (Options), a leading provider of financial services infrastructure, today announced major enhancements to its cutting-edge, real-time monitoring and alerting tool - AtlasVision.

After Peptide Sciences left patients mid-process, many individuals were suddenly forced to reassess ongoing peptide protocols without guidance. This disruption has created urgency, confusion, and increased risk around next steps. California Trim Clinic is helping patients navigate this transition with structured, physician-guided care designed to restore clarity, safety, and continuity.

MBP Global LLP is pleased to announce that Jatinder Singh will join the firm as a Tax Partner, effective April 15, 2026. Her appointment further enhances the firm’s capabilities in delivering sophisticated tax solutions to clients navigating complex U.S. and international regulatory environments.

Tilray Advances UK Healthcare Platform with Lyphe Acquisition, Positions BrewDog for Strong Growth, and Prepares for U.S. Rescheduling and Medical Cannabis Opportunity

NEW YORK CITY, NY / ACCESS Newswire / April 15, 2026 / Classover Holdings Inc. (NASDAQ:KIDZ) ("Classover" or the "Company"), an AI-driven education company, today announced that it has entered into a strategic collaboration with Luka, a developer of intelligent companion and educational robotics systems, to jointly explore the co-development of AI-driven learning scenarios in the North American market.

Toronto, Ontario--(Newsfile Corp. - April 15, 2026) - Vital Infrastructure Property Trust (TSX: VITL.UN) (the 'REIT' or 'Vital Infrastructure'), a...

Viant Technology Inc. (NASDAQ: DSP), a leader in CTV and AI-powered programmatic advertising, today announced it has entered into a definitive agreement to acquire TVision Insights, the only attention measurement provider delivering second-by-second, eyes-on-screen attention, co-viewership and in-room presence for TV.

LOS ANGELES, April 15, 2026 (GLOBE NEWSWIRE) -- CrownGuard Capital LLC, a direct balance sheet lender specializing in structured commercial real estate financing, is pleased to announce the successful closing of a $22,000,000 bridge loan to support the acquisition and development of a premier beach house property in Southern California.

Eddie and Kelley McGrath to receive Cardinal Cushing Award at 2026 Springtime Gala, honouring their philanthropy, recovery advocacy, and community impact.

LONDON, April 15, 2026 (GLOBE NEWSWIRE) -- A new white paper entitled “Inside the Science: A Major Step Forward for Knee Osteoarthritis” has been released which heralds the dawn of a new era of treatments for knee osteoarthritis (OA) that can offer a viable alternative to surgery on the NHS, currently facing a backlog of patients. Launched to coincide with the first major conference in the annual industry calendar – BASK 2026 (British Association of Surgery for the Knee) taking place on April 14-15th 2026 in Glasgow, the paper has been commissioned by Contura Orthopaedics Ltd.

VANCOUVER, BC / ACCESS Newswire / April 15, 2026 / Mako Mining Corp. (Nasdaq:MAKO)(TSX-V:MKO) ("Mako" or the "Company") is pleased to provide its first quarter 2026 ("Q1 2026") production results for the Company's San Albino gold mine ("San Albino") in northern Nicaragua and the Moss Mine in Arizona ("Moss Mine"), as well as to provide an update on its two advanced development projects in the United States and Guyana. Certain figures in this news release may not sum precisely due to rounding. Unless otherwise indicated, all amounts are expressed in U.S. dollars.

Toronto, Ontario--(Newsfile Corp. - April 15, 2026) - Seabridge Gold (TSX: SEA) (NYSE: SA) ("Seabridge" or the "Company") reports today its first...

Brisbane, Australia--(Newsfile Corp. - April 15, 2026) - Graphene Manufacturing Group Ltd. (TSXV: GMG) (OTCQX: GMGMF) ("GMG" or the "Company")...

Terremoto Biosciences, a biotechnology company developing highly targeted, small molecule medicines, today announced the closing of a $108 million Series C financing round. The round includes new investors RA Capital Management, Deep Track Capital, Osage University Partners (OUP), and BeOne Medicines, and participation from existing investors OrbiMed, Third Rock Ventures, Novo Holdings, and Cormorant Asset Management.

Graham Corporation (NYSE: GHM) (“GHM” or “the Company”), a global leader in the design and manufacture of mission critical fluid, power, heat transfer, vacuum, and advanced mixing technologies for the Defense, Energy & Process, and Space industries, today announced the Company has agreed to sell $50 million of shares (5%) of common stock to certain accounts advised by T. Rowe Price Investment Management, Inc. (“T. Rowe Price”), a global investment management organization.

U.S. Physical Therapy, Inc. (“USPH” or the “Company”) (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today announced the closing of a $450 million, five-year credit facility that includes a $175 million term loan and a $275 million revolver with a maturity date of April 14, 2031. Based on strong lender support, the credit facility was upsized from its initial $400 million launch amount. This is an increase and extension of the Company’s $325 million credit facility which was due to expire on June 17, 2027.

Flowserve Corporation (NYSE: FLS) (“Flowserve”) will release its first quarter 2026 earnings results after the market closes on Wednesday, April 29, 2026.

Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, today announced that VTAMA cream was granted a strong, evidence-based recommendation by the American Academy of Dermatology (AAD) in their 2026 guidelines for the management and treatment of atopic dermatitis (AD) in pediatric patients, published on April 7, 2026. The guidelines name VTAMA cream as the only steroid-free topical treatment the AAD found to be supported by a high certainty of evidence, that is indicated across all severities in children aged 2 years and older with AD. In the pivotal studies for VTAMA in AD, the most common adverse reactions (incidence ≥1%) were: upper respiratory tract infection, folliculitis, lower respiratory tract infection, headache, asthma, vomiting, ear infection, pain in extremity, and abdominal pain.

Energy Vault Holdings, Inc. (NYSE: NRGV) (“Energy Vault” or “the Company”), a global leader in sustainable, grid-scale energy storage solutions and AI compute infrastructure solutions, announced today that the Company will release its earnings results for the first quarter ended March 31, 2026 on Tuesday, May 5, 2026 followed by a conference call at 4:30 PM ET.

Fast Track designation has the potential to facilitate development and accelerate FDA review of imdusiran

SINGAPORE, April 15, 2026 (GLOBE NEWSWIRE) -- Bitdeer Technologies Group (NASDAQ: BTDR) (“Bitdeer” or the “Company”), a world-leading technology company for AI and Bitcoin mining infrastructure, today announced its unaudited operations updates for March 2026.

Habit brings back a fan favorite, but it’s hotter and smokier than ever with 20 percent off through April 21

WILMINGTON, Del., April 15, 2026 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Nasdaq: PRLD) (“Prelude Therapeutics” or the “Company”), a clinical-stage precision oncology company, today announced that Dr. Charles Morris will join the Company as Chief Medical Officer effective, April 20, 2026.

Vancouver, Canada, April 15, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery and development of novel, non-hallucinogenic, second generation, neuroplastogen-derived therapeutics to solve major under-treated health problems, today announced that its independent Data and Safety Monitoring Board (“DSMB”) has completed its review and issued a positive recommendation to continue the ongoing FDA-approved Phase I/IIa clinical trial of CMND-100 for the treatment of Alcohol Use Disorder (“AUD”).

Updated Safety, Efficacy, and Clinical Data Supports Teverelix as Potentially the First Long-Acting Injectable GnRH Antagonist Across Multiple Indications in Women’s Health

Boca Raton, FL, April 15, 2026 (GLOBE NEWSWIRE) -- Powell Max Limited (Nasdaq: PMAX) (“Powell Max” or the “Company”), a financial communications services provider, today announced a 1-for-10 share consolidation (the “Share Consolidation”) of all issued and outstanding ordinary shares, effective at the opening of trading on April 17, 2026. The Share Consolidation is intended to increase the market price per share of the Company’s Class A Ordinary Shares to a level above the US$1.00 minimum bid price requirement for continued listing on the Nasdaq Capital Market. The Share Consolidation will be effected pursuant to the Sixth Amended and Restated Memorandum and Articles of Association. The Company’s Class A Ordinary Shares (the “Class A Ordinary Shares”) will continue to trade on the Nasdaq Capital Market under the ticker symbol “PMAX” and will be assigned a new CUSIP Number: G7200G126.

Morgan Stanley (NYSE: MS) today announced its first quarter 2026 financial results. The results are now available on the Firm’s Investor Relations website at www.morganstanley.com/about-us-ir/earnings-releases. The results will be filed on a Form 8-K with the Securities and Exchange Commission (SEC) on April 15, 2026, which will be available on the SEC’s website at www.sec.gov.

INDIANAPOLIS, IN / ACCESS Newswire / April 15, 2026 / Arrive AI (NASDAQ:ARAI), an autonomous delivery network company built around patented, AI-powered Arrive Points™, today announced financial results for the fourth quarter and full year ended December 31, 2025, and provided an update on strategic, operational, and product development progress.